Indian pharma industry to grow at 19 per cent in 2013: Report
The Indian pharmaceutical industry will register a growth of 19 per cent in 2013, says Morgan Stanley.
Mumbai, January 10, 2013: As per the recent report from Morgan Stanley, the Indian pharmaceutical industry will grow at 19 per cent in 2013.
"We expect the intellectual property investments in the past few years to start bearing fruits in US and EU markets in FY13. There will be new drug launches, new drug filings and Phase II clinic trials throughout the year,” said Mr Samir Baisiwala, Senior Analyst, Morgan Stanley in his report. At the same time, the report also said that Japan and the emerging markets could also fuel the growth of the Indian pharmaceutical industry.
The report also provides stock ratings like overweight (buy) and equalweight (hold) to the largest pharmaceutical stocks. As per the report, the long-term strategy of companies like Sun Pharma, Lupin, Dr Reddy’s Lab appear better as compared to its counterparts.